Concepedia

Frank Markland

FM

Statistics

Publications

8

Citations

959

H-Index

8

Active since

1966

Affiliations

University of Southern California(Current)

Johns Hopkins Medicine

Johns Hopkins University

National Cancer Institute

Frank Markland is an author at University of Southern California specializing in biochemistry, medicine, and oncology.

Publications per year

1966–2011

8

Publications

8

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Agustin A. García, Hal W. Hirte, Gini F. Fleming et al. · Journal of Clinical Oncology · 2007 · 549 citations

, , +16

Vascular Targeting and Antiangiogenesis Agents Induce Drug Resistance Effector GRP78 within the Tumor Microenvironment

Dezheng Dong, Bryce Ko, Peter Baumeister et al. · Cancer Research · 2005 · 151 citations

, , +17

Adenosine Triphosphate-Adenosine 5'-Monophosphate Phosphotransferase of Bovine Liver Mitochondria

Frank Markland, Charles L. Wadkins · Journal of Biological Chemistry · 1966 · 78 citations · Full text

, , +13

Adenosine Triphosphate-Adenosine 5'-Monophosphate Phosphotransferase of Bovine Liver Mitochondria

Frank Markland, Charles L. Wadkins · Journal of Biological Chemistry · 1966 · 78 citations · Full text

, , +13

Integrin Agonists as Adjuvants in Chemotherapy for Melanoma

Martin A. Schwartz, Kevin S. McRoberts, Matthew Coyner et al. · Clinical Cancer Research · 2008 · 32 citations · Full text

, , +15

1–5 of 8